Redcare Pharmacy (SHPPF)

Tuesday

6:13 AM

ThesisThe recent strategic partnerships and potential for online expansion are generating positive sentiment among investors, countering concerns over margin pressures.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$2.9B	$3.5B	$3.9B
Rev. Growth	+24.0%	+18.6%	+12.0%
EPS	$-1.87	$-0.32	$1.13
EPS Growth	+17.3%	+82.8%	+453%
P/E (fwd)	—	—	57.3×

★ Analysts see FY2026 revenue reaching $3.5B — +18.6% growth in a single year.

Why Revenue Could Accelerate

01Redcare's recent partnership with a major healthcare provider is expected to increase distribution volumes by 15% over the next year.
02The company is in discussions to expand its online sales platform, which could increase market reach by 20%.
03Recent regulatory changes in the EU may streamline the approval process for new drugs, potentially benefiting Redcare's product offerings.
04Digital transformation in healthcare distribution
05Growing demand for personalized medicine
06Changes in pharmaceutical regulations in the EU
07Fluctuations in drug pricing due to market competition
08Partnerships with healthcare providers for exclusive distribution agreements

FY2025 Snapshot

Revenue: $2.9B
Rev. Growth: +24.0%
Gross Margin: 20.2%
Op. Margin: -0.8%
Net Margin: -1.3%
Net Income: $-38M
NI Growth: +17.1%
EPS: $-1.87
1Y Return: -56.3%

My Notes

"Management highlighted, 'Our partnerships are set to redefine our distribution capabilities and drive growth in the coming year.'"
Moat: Redcare's competitive advantage lies in its established logistics network and strong relationships with healthcare providers…
growth - Investors are likely attracted to the company's strong revenue growth and potential for market expansion.
Higher interest rates can increase financing costs for Redcare, impacting its ability to invest in growth initiatives and potentially…
Watch on earnings: Gross margin percentage, Revenue growth rate, Operating cash flow.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $3.5B to $3.9B as redcare's recent partnership with a major healthcare provider is expected to increase distribution volumes by 15%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.